The number of Netherlands residents using medicines like Ozempic, Wegovy, and Mounjaro for weight loss is increasing ...

A damaging trial failure in December wiped 70% off the share price of BioAge Labs, a US biopharma developing therapeutic ...

The use of weight loss drugs like Ozempic and Wegovy is growing in the Netherlands as more people opt to pay for ...

Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), Exxon Mobil ...

SLOWLY lifting her head off her sweat-drenched pillow, Aisleyne Horgan-Wallace vomits into the sick bucket next to her bed. ...

Why it matters: Lilly's growth prospects are driven by Mounjaro and Zepbound ... We also sell both admissions and sponsorship packages for our investment conferences and advertising on our ...

Tori Allen says she's thrilled to have lost 80 pounds since she went on Wegovy, one of the GLP-1 drugs that more and more people are using to treat diabetes or lose weight.

Just as quickly, investors are losing their appetite for the trade. After a disappointing trial of a new Novo Nordisk drug ...

A new study has considered some of the potential benefits and risks of glucagon-like peptide 1 receptor agonists (GLP-1RAs), ...

It appears an unintended side effect of the drug has now struck some of Britain's known suitmakers, who are fed up with ...

But, no matter what direction the general market takes, some stocks could stand out, potentially in 2025, and most ...